DeVos Invested More Money in 'Brain Performance' Company, Despite Weak Evidence
Rebecca Maynard of the Graduate School of Education critiques information distributed by a company, Neurocore, that makes questionable claims about its treatment for anxiety, depression, ADHD and autism.
・ From Education Week